Interestingly, the results of this study showed that the inhibition of AKT as well as PI3K could prevent the enhanced activation and adhesion of platelets on fibrinogen as well as pro-coagulant platelet formation in sera of COVID-19 patients. Here, AKT1 is linked to COVID-19.